No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
- 38.813
- +0.143+0.37%
Trading Jul 16 10:43 ET
79.14BMarket Cap13.75P/E (TTM)
38.865High38.460Low484.80KVolume38.510Open38.670Pre Close18.74MTurnover0.03%Turnover Ratio12.48P/E (Static)2.04BShares45.79552wk High4.41P/B76.55BFloat Cap32.69052wk Low1.47Dividend TTM1.97BShs Float45.795Historical High3.78%Div YieldTTM1.05%Amplitude6.508Historical Low38.660Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Global Drug Discovery Technologies Market Insights, 2024-2033 - Top 10 Companies Account for 26.61% of the Total Market; AstraZeneca Leads With 5.73% Share, Followed by Merck and GlaxoSmithKline
Unusual Options Activity: GOOG, BKR and Others Attract Market Bets, GOOG V/OI Ratio Reaches 357.1
EST Jul 11th Afternoon Delivery - In the last two hours of trading, 8 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
GSK to Deliver Over 36M Flu Shots for Fall Immunization Drive
GSK Begins Shipping Influenza Vaccine Doses for 2024-25 Season
GSK supports annual flu immunization by getting FLULAVAL and FLUARIX to patients in advance of flu season GSK plc (NYSE:GSK) today announced it has started shipping doses of its trivalent influenza vaccines to US
Is GSK an Attractive Drug Stock to Add to Your Portfolio Now?
GlaxoSmithKline (GSK) Receives a Buy From Deutsche Numis
Comments
$GlaxoSmithKline(GSK.US$ Very poor performance stock. Not suprise in the end of 2024, it will be worth around $25
I am quite stumped about $GlaxoSmithKline(GSK.US$ in the past few weeks. It has had fairly steady long-term growth in the past few years and there doesn't seem to be that much worrying news recently. Is it just going through an oscillation at the moment?
$GlaxoSmithKline(GSK.US$ is this going for 52 week low? or a buy now?
3
The term 'GRANOLAS' was coined by Goldman Sachs in 2020 based on a loose acronym of the stocks' names. It includes GlaxoSmithKline, Roche, ASML, Nestlé, Novartis, Novo Nordisk, L'Oréal, LVMH, AstraZeneca, SAP and Sanofi.
3
🚨 1 AdCom & 3 PDUFA decisions this week:
$Genfit(GNFT.US$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD(IPSEY.US$ : 🤔
⇨ Elafibranor
‣ Primary biliary cholangitis
‣ PDUFA date: 6/10/24
$Regeneron Pharmaceuticals(REGN.US$ : 🤔
⇨ Kevzara (sarilumab)
‣ Polyarticular juvenile idiopathic arthritis
‣ PDUFA date: 6/10/24
$Bristol-Myers Squibb(BMY.US$ : 🤔
⇨ Augtyro™ (Repotrectinib)
‣ PDUFA date: 6/15/24 (sNDA)
🗓️ Last week’s PDUFAs:
$GlaxoSmithKline(GSK.US$ : Approved 6/7 🎉
⇨ Arexvy
‣ Respiratory s...
$Genfit(GNFT.US$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD(IPSEY.US$ : 🤔
⇨ Elafibranor
‣ Primary biliary cholangitis
‣ PDUFA date: 6/10/24
$Regeneron Pharmaceuticals(REGN.US$ : 🤔
⇨ Kevzara (sarilumab)
‣ Polyarticular juvenile idiopathic arthritis
‣ PDUFA date: 6/10/24
$Bristol-Myers Squibb(BMY.US$ : 🤔
⇨ Augtyro™ (Repotrectinib)
‣ PDUFA date: 6/15/24 (sNDA)
🗓️ Last week’s PDUFAs:
$GlaxoSmithKline(GSK.US$ : Approved 6/7 🎉
⇨ Arexvy
‣ Respiratory s...
9
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
